findmyKOL

Ann Camac, MD

Basic profile

Lahey Hospital and Medical Center

ORCIDNone on fileNPI
RegionBurlington, MA · NortheastSpecialtyNeurologyFocusNeurology
Last active 2017findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2017Online presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Ann Camac is a Neurology physician affiliated with Lahey Hospital and Medical Center. OpenAlex indexes 7 publications with 238 citations (h-index 4); ClinicalTrials.gov lists 1 registered study matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
7publications

Distinct works indexed by OpenAlex.

238citations

Total citations across indexed works.

4h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Lahey Clinic
41 Mall Road
Burlington, MA 018050001

Telephone

781-744-8000

Registry record last updated 27 Oct 2010.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2020)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    47.3%
    Gabapentinoids17.1%
    Gabapentin100%
    Part D17 patients
    Other antiepileptics14.3%
    Levetiracetam54%Topiramate46%
    Part D<11 patients

    + 3 more classes in this area

  • Cancer & immunology

    34.7%
    Other immunostimulants21.2%
    Glatiramer Acetate64%Copaxone37%
    Part D<11 patients
    Pyrimidine Synthesis Inhibitor7.8%
    Aubagio100%
    Part D<11 patients

    + 1 more class in this area

  • Musculoskeletal

    18%
    gamma-Aminobutyric Acid-ergic Agonist18%
    Baclofen100%
    Part D26 patients
Where care is delivered (Part B), 201940.7% facility · 59.3% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”